CBD and the future of Fanta | Brazcann

Beverages

A future scenario: CBD at Fanta

Fanta could create an adult wellness beverage with CBD. Launch an adult beverage with cannabidiol under Fanta, adding wellness to its fruity, young profile. Below, an independent strategic analysis by Brazcann on how this would be possible — and what the brand stands to gain.

If you're looking for «Fanta hemp», «Fanta and cannabis» or a cannabis soft drink linked to Fanta, this report brings together the science, the potential of industrial cannabis and the business path behind the idea.

Fanta's current challenge

Fanta competes in a declining soda market and Coca-Cola seeks to diversify into functional drinks. Occupying the adult-wellness occasion is strategic.

The science behind: cannabinoids and electrolytes

Cannabidiol (CBD) is a non-psychoactive cannabinoid studied for anxiolytic and anti-inflammatory effects. Worldwide there is already a market for CBD beverages (Lagunitas, part of the Heineken group, launched Hi-Fi Hops). Combined with electrolytes (sodium, potassium, magnesium) for hydration, the concept targets wellness and recovery. It is a space that demands regulatory rigor: the sale of cannabinoid beverages is restricted and varies by country.

CBD: a non-psychoactive cannabinoid, without THC's "euphoria" effect.
Electrolytes replenish mineral salts lost through hydration.
A growing wellness/functional category abroad.
An adult, premium positioning, distinct from a regular soft drink.

How Fanta would apply cannabinoids and electrolytes

Fanta could develop a fruity adult beverage with CBD, positioned for wellness, where regulation allows.

A possible path

Assess the regulation for CBD in beverages.
Formulate a fruity adult version with CBD.
Position it for wellness.

The potential gain (hypothetical scenario)

In a hypothetical scenario, Fanta would open an adult functional front with CBD — dependent on regulation.

Sustainability: Bets on plant-based ingredients and a wellness positioning, aligned with conscious-consumption trends.

The link with Brazil and Brazcann

In Brazil, products with cannabinoids are regulated by Anvisa (RDC 660/2022 and the new framework RDC 1,015/2026); a free-sale CBD beverage is not yet permitted — so the scenario is strategic/forward-looking, dependent on regulatory evolution.

Brazcann operates precisely at this bridge: regulatory intelligence, importing and structuring cannabis and hemp businesses in Brazil — helping companies turn scenarios like this into viable, Anvisa-compliant projects.

Frequently asked questions

Does it have a psychoactive effect?

No: CBD does not cause euphoria; the proposal is wellness.

Why CBD?

It helps diversify into functional beverages as soda loses ground.

Is there a marijuana soft drink?

The popular term is "marijuana", but the correct material here is industrial hemp — Cannabis sativa with THC ≤ 0.3%, with no psychoactive effect. It is the source of cannabinoids and electrolytes in this analysis. It is not a drug, but a renewable, sustainable industrial material.